Inventor
Henry Daniell
Inventor
Winter Park, FL, US
Overview
Patents· 30 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes33%
C07KPeptides17%
A61KPreparations for medical, dental or toiletry purposes14%
Y02ATechnologies for adaptation to climate change12%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations9%
C12YEnzymes9%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%
A23KFodder1%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for1%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation1%
PatentTitleYear
11,007,247Compositions and methods for delivery of bioencapsulated proteins across blood-brain and retinal barriers202110,889,825Compositions and methods thereof for down-regulation of genes following oral delivery of an RNAi molecule bioencapsulated within plant cells202110,865,419Orally administered plastid expressed cholera toxin B subunit-exendin 4 as treatment for type 2 diabetes202010,806,775Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertensions, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders202010,752,909Chloroplasts engineered to express pharmaceutical proteins in edible plants202010,689,633Expression of b-mannanase in chloroplasts and its utilization in lignocellulosic woody biomass hydrolysis202010,676,751Production and use of plant degrading materials202010,655,135Orally administered plastid expressed cholera toxin B subunit-exendin 4 as treatment for type 2 diabetes202010,556,932Compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients202010,314,893Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimental induced ocular disorders201910,233,216Compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients201910,106,585Compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients20189,885,055'Chloroplasts engineered to express pharmaceutical proteins'20189,724,400'Administration of plant expressed oral tolerance agents'20179,657,302'Expression of human interferon in transgenic chloroplasts'20179,605,045'Expression of the human IGF-1 in transgenic plastids'20177,803,991'Universal chloroplast integration and expression vectors, transformed plants and products thereof'20107,795,497'Marker free transgenic plants: engineering the chloroplast genome without the use of antibiotic selection'20107,767,885'Plastid genetic engineering via somatic embryogenesis'20107,741,536'Expression of human serum albumin in plastids'20107,354,760'Expression of protective antigens in transgenic chloroplasts'20087,329,802'Genetic engineering of cotton to increase fiber strength, water absorption and dye binding'20087,294,506'Tobacco chloroplast transformation vectors comprising a multi-gene operon encoding a biopharmaceutical protein and a chaperonin'20077,135,620'Genetic engineering of plant chloroplasts'20067,129,391'Universal chloroplast integration and expression vectors, transformed plants and products thereof'20066,680,426'Genetic engineering of plant chloroplasts'20046,642,053'Genetic engineering of plant chloroplasts'20036,004,782'Hyperexpression of bioelastic polypeptides'19995,932,479'Genetic engineering of plant chloroplasts'19995,693,507'Genetic engineering of plant chloroplasts'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2010Patents assigned to UNIV AUBURN (8)· patent assignee history
1997–2003Based in Moscow, ID, US· patent location history
1999–2006Based in Auburn, AL, US· patent location history
2004–2020Based in Winter Park, FL, US· patent location history
2007–2010Patents assigned to UNIV CENTRAL FLORIDA RES FOUND (5)· patent assignee history
2008–2021Patents assigned to DANIELL HENRY (6)· patent assignee history
2017–2021Patents assigned to UNIV PENNSYLVANIA (14)· patent assignee history
2017–2021Based in Media, PA, US· patent location history
2019–2020Patents assigned to UNIV FLORIDA (3)· patent assignee history
2020Based in Philadelphia, PA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV PENNSYLVANIA | 14 | 2017–2021 |
| UNIV AUBURN | 8 | 1997–2010 |
| DANIELL HENRYself | 6 | 2008–2021 |
| UNIV CENTRAL FLORIDA RES FOUND | 5 | 2007–2010 |
| UNIV FLORIDA | 3 | 2019–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Winter Park, Florida, US | 13 | 2004–2020 |
| Media, Pennsylvania, US | 9 | 2017–2021 |
| Moscow, ID, US | 3 | 1997–2003 |
| Philadelphia, Pennsylvania, US | 2 | 2020 |
| Auburn, AL, US | 2 | 1999–2006 |